The Clinician's Interview‐Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response-Reference-Cited by-同舟云学术

The Clinician's Interview‐Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response

Published:2021-04-29 Issue:5 Volume:17 Page:856-865
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Stanley Justin¹,Howlett Susan E.¹²³,Dunn Taylor¹,Rockwood Kenneth¹²^ORCID

Affiliation:

1. DGI Clinical Inc. Halifax Nova Scotia Canada

2. Division of Geriatric Medicine Dalhousie University Halifax Nova Scotia Canada

3. Department of Pharmacology Dalhousie University Halifax Nova Scotia Canada

Funder

Atlantic Canada Opportunities Agency

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12242

Reference41 articles.

1. Cerebrolysin for vascular dementia;Cui S;Cochrane Database Syst Rev,2019

2. Donepezil for dementia due to Alzheimer's disease;Birks JS;Cochrane Database Syst Rev,2018

3. Rivastigmine for Alzheimer's disease;Birks JS;Cochrane Database Syst Rev,2015

4. Galantamine for vascular cognitive impairment;Birks J;Cochrane Database Syst Rev,2006

5. Validity and reliability of the Alzheimer's disease cooperative study‐clinical global impression of change. The Alzheimer's Disease Cooperative Study;Schneider LS;Alzheimer Dis Assoc Disord,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease;Alzheimer's & Dementia;2024-09-06

2. Que sait-on de la mémantine comme traitement de la maladie d’Alzheimer en 2024 ?;NPG Neurologie - Psychiatrie - Gériatrie;2024-09

3. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer’s Disease: A Review;The Yale Journal of Biology and Medicine;2024-06-28

4. Feasibility of Goal Attainment Scaling as a patient-reported outcome measure for older patients in primary care;Journal of Patient-Reported Outcomes;2023-07-24

5. How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy;Pharmaceutical Statistics;2023-05-22